4//SEC Filing
Campbell Bradley L 4
Accession 0000950170-25-020034
CIK 0001178879other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 5:14 PM ET
Size
6.0 KB
Accession
0000950170-25-020034
Insider Transaction Report
Form 4
Campbell Bradley L
DirectorPresident and CEO
Transactions
- Award
Common Stock
2025-02-11+137,075→ 1,220,768 total - Tax Payment
Common Stock
2025-02-11$9.57/sh−70,711$676,704→ 1,150,657 total
Footnotes (1)
- [F1]Granted for the achievement of the 2022 PRSUs as determined by the Board of Directors.
Documents
Issuer
AMICUS THERAPEUTICS, INC.
CIK 0001178879
Entity typeother
Related Parties
1- filerCIK 0001400971
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 5:14 PM ET
- Size
- 6.0 KB